| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/28/2001 | EP1086085A1 INHIBITORS OF p38 |
| 03/28/2001 | EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP1085896A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 03/28/2001 | EP1085871A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/28/2001 | EP1085869A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 03/28/2001 | EP1085816A1 Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 03/28/2001 | EP0921796B1 Tetrahydrolipstatin containing compositions |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/28/2001 | CN1289335A Azolo triazizes and pyrimidines |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289251A synergistic mixtures of natural products |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288750A Hypoglycemic slimming medicine and its preparation |
| 03/28/2001 | CN1288747A Composite medicine containing dihydromyricetrin |
| 03/28/2001 | CN1288732A Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process |
| 03/28/2001 | CN1288726A Medicine preparation containing ferrous saccharin |
| 03/28/2001 | CN1063645C Compound Chinese and western medicinal composition for treating 'zhongxiao' type diabetes |
| 03/28/2001 | CN1063644C Compound Chinese and western medicinal composition for treating diabetes of 'shangxiao' type |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207689 Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments |
| 03/27/2001 | US6207638 For enhancing and extending post meal satiety by stimulating cholecystokinin levels in a calorically efficient manner for reducing weight, comprising protein consisting of casein, whey and soy, glycomacropeptide, long chain fatty acids, fibers |
| 03/27/2001 | US6207163 Hydration compositions for human or animal bodies |
| 03/27/2001 | US6207159 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 03/27/2001 | CA2198258C Amino acid chelates having improved palatability |
| 03/27/2001 | CA2091562C Indole derivatives useful in psychotherapeutics |
| 03/27/2001 | CA2016985C Dehydrocholecalciferol derivatives |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/22/2001 | WO2001020327A1 Spa in a screening method for modulators of glucokinase |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019839A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | WO2001019542A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | WO2001019401A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019396A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 03/22/2001 | WO2001019383A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 03/22/2001 | WO2001019378A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 03/22/2001 | WO2001019356A2 High lipid diet |
| 03/22/2001 | WO2001019340A1 Dispersion formulations containing lipase inhibitors |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001019158A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 03/22/2001 | WO2001000811A3 17867, a novel human aminopeptidase |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | CA2383402A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2382683A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols |
| 03/22/2001 | CA2382008A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 03/21/2001 | EP1084705A2 Method for lowering blood glucose levels in mammals |
| 03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084103A1 New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 03/21/2001 | EP1084102A1 New 3-aryl propionic acid derivatives and analogs |
| 03/21/2001 | EP1084101A1 New 3-aryl-2-hydroxypropionic acid derivative iii |
| 03/21/2001 | EP1083930A1 Insulin supplemented infant formula |
| 03/21/2001 | EP1083924A1 Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083905A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (dhea) or analogues |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | EP1083797A1 Acid and solvent modification of psyllium |
| 03/21/2001 | EP0762877B1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/21/2001 | EP0681569B1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/21/2001 | CN1288458A Triazepinones, process for their prepn. and their therapeutic application |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288381A Fat-binding polymers |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288008A Sulfur-bearing phospho acid compound, pharmaceutical composite and use in prepn. of medicine |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1288006A Soya total flavone, its prepn. method and use thereof |
| 03/21/2001 | CN1287833A Zinc enriched medicine |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof |
| 03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |